Akebia Therapeutics, Inc. current report, 09 September 2019

Business Context and Reporting Period

This Form 8-K was filed by Akebia Therapeutics, Inc. (AKBA) on September 11, 2019, reporting an event that occurred on September 9, 2019. The filing details a material definitive agreement involving Keryx Biopharmaceuticals, Inc., a wholly owned subsidiary of Akebia.

Key Financial Metrics

This filing does not report standard financial performance metrics such as revenue, profit, cash flow, or debt levels. The primary financial data relates to the terms of a new sublease agreement:

  • Property Size: Approximately 27,300 rentable square feet located at One Marina Park Drive, Boston, Massachusetts.
  • Initial Base Rent: $146,861.13 per month ($64.50 per square foot per year).
  • Rent Escalation: Monthly base rent increases by $1.00 per square foot annually starting in the thirteenth full calendar month of the term.
  • Additional Costs: Subtenant pays a pro rata share of annual operating expenses and taxes.
  • Guaranty: Akebia has guaranteed Keryx's obligations under the Sublease.

Material Changes Versus Prior Period

The filing does not provide comparative financial data against prior periods. The material change is the execution of a Sublease with Foundation Medicine, Inc., effective from the later of September 15, 2019, or the date of Landlord consent, expiring on February 27, 2023. This action transfers the lease obligations for the specified premises to the Subtenant.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of general business risks. The primary contingency noted is that the Sublease term commences only after the Landlord (Fallon Cornerstone One MPD LLC) provides written consent. The Subtenant's obligations are subject to the terms of the original Lease dated April 29, 2015.

Investor Verification Checklist

  • Confirm the date the Landlord provides written consent to finalize the Sublease Commencement Date.
  • Verify the impact of the rent payments on Akebia's cash flow once the Subtenant begins paying rent one month after the Commencement Date.
  • Review the full text of the Sublease when filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2019.
  • Assess the extent of Akebia's liability under the guaranty of Keryx's obligations.